FELIQS CORPORATION : Developing novel therapy targeting oxidized lipids
Location: Japan
Investors 1
| Date | Name | Website |
| - | FFG Ventur... | ffg-ventur... |
Mentions in press and media 1
| Date | Title | Description |
| 02.07.2025 | FELIQS: $9 Million Series A Raised For Advancing FLQ-101 Clinical Program For Retinopathy Of Prematurity | FELIQS, a biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases, announced the completion of a $9 million Series A funding round, co-led by a major American... |